AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Share Issue/Capital Change Nov 18, 2019

165_rns_2019-11-18_21f7981a-9499-477b-bc5e-d6f8d611f470.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Other Capital Market Information | 18 November 2019 09:48

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052

18.11.2019 / 09:48

Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

– Share buy-back – 22 nd Interim Report

In the period from November 11, 2019 until and including November 15, 2019, a total of 174,687 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in number of shares Weighted average share price

in EUR
11.11.2019 35,000 67.3409
12.11.2019 35,000 66.7128
13.11.2019 35,000 65.8681
14.11.2019 34,687 65.8113
15.11.2019 35,000 65.7392

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including November 15, 2019 therefore amounts to 4,078,422 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA

represented by Fresenius Medical Care Management AG

represented by its Management Board

Bad Homburg v.d.H., November 18, 2019


18.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.